KIDS icon

OrthoPediatrics

22.38 USD
-0.21
0.93%
At close Dec 20, 4:00 PM EST
After hours
22.38
+0.00
0.00%
1 day
-0.93%
5 days
1.40%
1 month
-12.24%
3 months
-22.13%
6 months
-23.51%
Year to date
-32.20%
1 year
-29.80%
5 years
-47.34%
10 years
16.44%
 

About: OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Employees: 247

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

5,350% more call options, than puts

Call options by funds: $436K | Put options by funds: $8K

33% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 36

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

2% more funds holding

Funds holding: 122 [Q2] → 124 (+2) [Q3]

2.07% less ownership

Funds ownership: 69.55% [Q2] → 67.48% (-2.07%) [Q3]

7% less capital invested

Capital invested by funds: $477M [Q2] → $443M (-$33.8M) [Q3]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$25
12%
upside
Avg. target
$34
50%
upside
High target
$42
88%
upside

2 analyst ratings

positive
50%
neutral
50%
negative
0%
Truist Securities
Richard Newitter
80% 1-year accuracy
40 / 50 met price target
12%upside
$25
Hold
Maintained
18 Dec 2024
Needham
Mike Matson
50% 1-year accuracy
58 / 117 met price target
88%upside
$42
Buy
Reiterated
8 Nov 2024

Financial journalist opinion

Based on 3 articles about KIDS published over the past 30 days

Neutral
GlobeNewsWire
2 weeks ago
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
WARSAW, Ind., Dec. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics today announced that the OrthoPediatrics Specialty Bracing (OPSB™) division is expanding its product offering with the launch of two new products including the OPSB Sensor System and MOVE-D™.
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
Neutral
GlobeNewsWire
2 weeks ago
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
WARSAW, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and its continued support of the event as an Emerald-Level sponsor.
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
Neutral
GlobeNewsWire
3 weeks ago
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace
WARSAW, Ind., Nov. 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company dedicated exclusively to advancing the field of pediatric orthopedics, is excited to announce significant updates to the DF2® Brace, a cornerstone product within the OrthoPediatrics Specialty Bracing business (“OPSB”). The DF2 Brace updates include expanded indications for use, enhanced sizing options, and additional international markets.
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace
Neutral
Seeking Alpha
1 month ago
OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Trip Taylor - Gilmartin Group David Bailey - President & Chief Executive Officer Fred Hite - Chief Financial Officer & Chief Operating Officer Conference Call Participants Matt O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Good morning and welcome to OrthoPediatrics Corporation's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Compared to Estimates, OrthoPediatrics (KIDS) Q3 Earnings: A Look at Key Metrics
The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, OrthoPediatrics (KIDS) Q3 Earnings: A Look at Key Metrics
Negative
Zacks Investment Research
1 month ago
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.13 per share a year ago.
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
WARSAW, Ind., Nov. 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2024.
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
WARSAW, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2024 financial results on Wednesday, November 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Thursday, November 7, 2024, at 8:00 a.m. ET to discuss the results.
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
Positive
Zacks Investment Research
2 months ago
What Makes OrthoPediatrics (KIDS) a New Strong Buy Stock
OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes OrthoPediatrics (KIDS) a New Strong Buy Stock
Positive
Zacks Investment Research
2 months ago
Down -15.65% in 4 Weeks, Here's Why You Should You Buy the Dip in OrthoPediatrics (KIDS)
OrthoPediatrics (KIDS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down -15.65% in 4 Weeks, Here's Why You Should You Buy the Dip in OrthoPediatrics (KIDS)
Charts implemented using Lightweight Charts™